Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Methotrexate and Zidovudine with Radiotherapy for HIV-PCNSL
NCT00003261Phase 2Unknown
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- May 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate and zidovudine in primary central nervous system lymphoma (PCNSL), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoints: Efficacy of neoadjuvant chemotherapy and radiation therapy, Toxicity and 1 more. Status: unknown.
02
Drugs
methotrexatezidovudine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00003261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003261.